CBP-1018-101

An Open-Label, Non-randomized, Multinational, Multi-center Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Bi-Ligand-Drug Conjugate CBP-1018 First in Patients with Advanced Solid Tumors

Locations


Sun Yat-Sen Memoprial Hospital Sun Yat-Sen University


Guangzhou,China

Recruiting


Tianjin Medical University Cancer Institute & Hospital


Tianjin,China

Recruiting


West China Hospital of Sichuan University


Chengdu,China

Recruiting


Zhongshan Hospital Red Cross Hospital


Shanghai,China

Recruiting
Shanghai Tenth Hospital Of Tongji University


Shanghai,China

Recruiting


Zhejiang Provincial People’s Hospital


Hangzhou,China

Recruiting
The Second Affiliated Hospital Zhejiang University School of Medicine


Hangzhou,China

Recruiting


Nanjin Drum Tower Hospital


Nanjing,China

Recruiting


The First Affilated Of Ningbo University


Ningbo,China

Recruiting


Zhejiang Cancer Hospital


Hangzhou,China

Recruiting


Shandong Cancer Hospital


Jinan,China

Recruiting


The First Affiliated Hospital Wenzhou University School of Medicine


Wenzhou,China

Recruiting


Chongqing Cancer Hospital


Chongqing,China

Recruiting